MedTrace Logo

Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes

NCT00700830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1976

Last updated 2014-08-15

No results posted yet for this study

Summary

This study is conducted in Africa. The aim of this study is to assess the safety and efficacy of Levemir® treatment for insulin naive patients with type 2 diabetes under normal clinical practice conditions in Algeria.

Conditions

Interventions

DRUG

insulin detemir

Initial dosage and the following dosages will be prescribed by the physician as a result of a normal clinical evaluation

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • Algeria

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700830 on ClinicalTrials.gov